Sarepta Therapeutics, Inc.

SRPT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$613,077$510,598$240,867$1,103,010
Short-Term Investments$237,916$289,541$281,895$251,782
Receivables$541,604$609,595$724,524$649,728
Inventory$1,077,166$994,036$941,432$749,960
Other Curr. Assets$13,861$11,039$7,986$9,214
Total Curr. Assets$2,722,309$2,656,985$2,432,533$3,073,463
Property Plant & Equip (Net)$498,103$514,898$507,650$488,646
Goodwill$0$0$0$0
Intangibles$29,684$30,522$26,199$26,887
Long-Term Investments$9,205$34,604$109,125$136,873
Tax Assets$2,275$0$0$0
Other NC Assets$231,861$442,805$389,880$237,304
Total NC Assets$771,128$1,022,829$1,032,854$889,710
Other Assets$0$0$0$0
Total Assets$3,493,437$3,679,814$3,465,387$3,963,173
Liabilities
Payables$94,015$136,702$156,105$214,442
Short-Term Debt$0$0$0$0
Tax Payable$0$18,730$79,864$17,391
Deferred Revenue$485,449$395,431$44,859$130,256
Other Curr. Liab.$206,147$210,923$166,622$200,276
Total Curr. Liab.$921,425$919,948$605,588$731,684
LT Debt$1,035,146$1,139,458$1,138,289$1,137,124
Deferred Rev, NC$0$0$325,000$325,000
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,704$48,604$48,327$49,150
Total NC Liab.$1,251,892$1,402,481$1,717,076$1,703,747
Other Liabilities$0$0$0$0
Cap. Leases$225,210$214,419$205,460$205,946
Total Liabilities$2,173,317$2,322,429$2,322,664$2,435,431
Equity
Pref Stock$0$0$0$0
Common Stock$11$10$10$10
Retained Earnings-$4,641,537-$4,461,590-$4,658,482-$4,210,974
AOCI$220-$51$34-$218
Other Equity$0$0$0$0
Total Equity$1,320,120$1,357,385$1,142,723$1,527,742
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$3,493,437$3,679,814$3,465,387$3,963,173
Net Debt$422,069$628,860$897,422$34,114
Sarepta Therapeutics, Inc. (SRPT) Financial Statements & Key Stats | AlphaPilot